Sivik Global Healthcare LLC

In its 13F for Q4 2025 (holdings as of December 31, 2025, filed January 21, 2026), Sivik Global Healthcare LLC reported 41 stock positions worth $204.8 million. Its top holding was SS SPDR S&P Biotech ETF (XBI) at 13.4% of the portfolio, followed by Eli Lilly (LLY, 3.7%) and Tenet Healthcare (THC, 3.6%). Compared with Q3 2025, it opened 13 new positions, sold out of 7, added to 9 and reduced 14. The biggest buy was a new position in Mettler-Toledo International (MTD) and the biggest sale an exit from Johnson & Johnson (JNJ).

Most Recent 13F
Q2 2026
Location
GREENWICH, CT
CIK
0001596452
Portfolio Value
$204.8M (Q4 2025)
SEC Filing
0001596452-26-000002 ↗ filed Jan 21, 2026

Holdings Value

0$100.0M$200.0M$300.0M Q1 2024: $275.1M Q1 2024 Q2 2024: $223.9M Q2 2024 Q3 2024: $234.6M Q3 2024 Q4 2024: $180.8M Q4 2024 Q1 2025: $182.9M Q1 2025 Q2 2025: $223.6M Q2 2025 Q3 2025: $190.5M Q3 2025 Q4 2025: $204.8M $204.8M Q4 2025 Q1 2026: $131.7M Q1 2026 Q2 2026: $131.7M Q2 2026

Holdings 41 stocks · $204.8M
XBI SS SPDR S&P Biotech ETF 13.39% 225,000 $27.4M Reduce -10.0%
LLY Eli Lilly & Co. 3.67% 7,000 $7.5M Reduce -30.0%
THC Tenet Healthcare Corp. 3.64% 37,500 $7.5M Add +7.1%
MCK McKesson Corp. 3.60% 9,000 $7.4M Add +28.6%
HCA HCA Healthcare Inc. 3.42% 15,000 $7.0M Reduce -11.8%
TMO Thermo Fisher Scientific Inc. 3.39% 12,000 $7.0M Reduce -14.3%
CAH Cardinal Health Inc. 3.26% 32,500 $6.7M Reduce -13.3%
BSX Boston Scientific Corp. 3.26% 70,000 $6.7M No change
VRTX Vertex Pharmaceuticals Inc. 3.05% 13,770 $6.2M Reduce -1.6%
UHS Universal Health Services-B 2.98% 28,000 $6.1M No change
COR Cencora Inc. 2.97% 18,000 $6.1M Reduce -10.0%
ISRG Intuitive Surgical Inc. 2.77% 10,000 $5.7M Reduce -23.1%
EHC Encompass Health Corp. 2.59% 50,000 $5.3M Add +42.9%
DHR Danaher Corp. 2.57% 23,000 $5.3M Reduce -34.3%
ABT Abbott Laboratories 2.45% 40,000 $5.0M Add +6.7%
A Agilent Technologies Inc. 2.33% 35,000 $4.8M Add +6.1%
ABBV Abbvie Inc. 2.23% 20,000 $4.6M No change
SYK Stryker Corp. 2.23% 13,000 $4.6M No change
MDT Medtronic PLC 2.11% 45,000 $4.3M Reduce -25.0%
MTD Mettler-Toledo International 2.04% 3,000 $4.2M New
SNN Smith & Nephew PLC -Spon ADR 2.00% 125,000 $4.1M Reduce -21.9%
RGEN Repligen Corp. 2.00% 25,000 $4.1M Reduce -9.1%
UNH Unitedhealth Group Inc. 1.93% 12,000 $4.0M No change
BDX Becton Dickinson and Co. 1.89% 20,000 $3.9M New
HUM Humana Inc. 1.88% 15,000 $3.8M Reduce -40.0%
NVO Novo-Nordisk A/S-Spons ADR 1.86% 75,000 $3.8M New
AZN Astrazeneca PLC-Spons ADR 1.80% 40,000 $3.7M New
BIO Bio-Rad Laboratories-A 1.78% 12,000 $3.6M Add +9.1%
BIIB Biogen Inc. 1.72% 20,000 $3.5M New
GMED Globus Medical Inc. Class A 1.70% 40,000 $3.5M New
MRK Merck & Co. Inc. 1.54% 30,000 $3.2M New
SGRY Surgery Partners Inc. 1.51% 200,000 $3.1M Reduce -9.1%
GILD Gilead Sciences Inc. 1.50% 25,000 $3.1M New
BRKR Bruker Corp. 1.50% 65,000 $3.1M Add +8.3%
EW Edwards Lifesciences Corp. 1.46% 35,000 $3.0M New
GEHC GE Healthcare Technology 1.40% 35,000 $2.9M Add +40.0%
SEM Select Medical Holdings Corp. 1.38% 190,000 $2.8M Add +8.6%
TECH Bio-Techne Corp. 1.29% 45,000 $2.6M New
CGON CG Oncology Inc. 0.71% 35,000 $1.5M New
ARGX Argenx SE - ADR 0.62% 1,500 $1.3M New
ALNY Alnylam Pharmaceuticals Inc. 0.58% 3,000 $1.2M New

Options reported separately and not counted above: PUT - SPY 100 @ 684 EXP 01/30/2026 puts ($20.5M), PUT - SPY 100 @ 680 EXP 02/20/2026 puts ($17.0M), PUT - SPY 100 @ 688 EXP 01/30/2026 puts ($17.0M), PUT - SPY 100 @ 679 EXP 01/30/2026 puts ($17.0M), PUT - SPY 100 @ 682 EXP 01/30/2026 puts ($17.0M), PUT - SPY 100 @ 681 EXP 01/30/2026 puts ($17.0M), PUT - SPY 100 @ 683 EXP 01/30/2026 puts ($17.0M), PUT - SPY 100 @ 682 EXP 02/20/2026 puts ($17.0M).

Portfolio Sells Q3 2025 → Q4 2025
JNJ Johnson & Johnson Sold out 0.00% −2.43
CI The Cigna Group Sold out 0.00% −2.12
ZBH Zimmer Biomet Holdings Inc. Sold out 0.00% −2.07
WST West Pharmaceutical Services Sold out 0.00% −2.07
DGX Quest Diagnostics Inc. Sold out 0.00% −2.00
HUM Humana Inc. Reduce -40.0% 1.88% −1.54
LH Labcorp Holdings Inc. Sold out 0.00% −1.51
STVN Stevanato Group SPA Sold out 0.00% −1.15
DHR Danaher Corp. Reduce -34.3% 2.57% −1.07
SNN Smith & Nephew PLC -Spon ADR Reduce -21.9% 2.00% −1.05
SGRY Surgery Partners Inc. Reduce -9.1% 1.51% −0.99
MDT Medtronic PLC Reduce -25.0% 2.11% −0.89
HCA HCA Healthcare Inc. Reduce -11.8% 3.42% −0.38
LLY Eli Lilly & Co. Reduce -30.0% 3.67% −0.33
COR Cencora Inc. Reduce -10.0% 2.97% −0.31
ISRG Intuitive Surgical Inc. Reduce -23.1% 2.77% −0.29
TMO Thermo Fisher Scientific Inc. Reduce -14.3% 3.39% −0.17
RGEN Repligen Corp. Reduce -9.1% 2.00% +0.07
VRTX Vertex Pharmaceuticals Inc. Reduce -1.6% 3.05% +0.17
CAH Cardinal Health Inc. Reduce -13.3% 3.26% +0.17
XBI SS SPDR S&P Biotech ETF Reduce -10.0% 13.39% +0.24

Portfolio Buys Q3 2025 → Q4 2025
MTD Mettler-Toledo International New 2.04% +2.04
BDX Becton Dickinson and Co. New 1.89% +1.89
NVO Novo-Nordisk A/S-Spons ADR New 1.86% +1.86
AZN Astrazeneca PLC-Spons ADR New 1.80% +1.80
BIIB Biogen Inc. New 1.72% +1.72
GMED Globus Medical Inc. Class A New 1.70% +1.70
MRK Merck & Co. Inc. New 1.54% +1.54
GILD Gilead Sciences Inc. New 1.50% +1.50
EW Edwards Lifesciences Corp. New 1.46% +1.46
TECH Bio-Techne Corp. New 1.29% +1.29
MCK McKesson Corp. Add +28.6% 3.60% +0.77
CGON CG Oncology Inc. New 0.71% +0.71
ARGX Argenx SE - ADR New 0.62% +0.62
ALNY Alnylam Pharmaceuticals Inc. New 0.58% +0.58
BRKR Bruker Corp. Add +8.3% 1.50% +0.47
GEHC GE Healthcare Technology Add +40.0% 1.40% +0.42
EHC Encompass Health Corp. Add +42.9% 2.59% +0.26
SEM Select Medical Holdings Corp. Add +8.6% 1.38% +0.20
BIO Bio-Rad Laboratories-A Add +9.1% 1.78% +0.16
A Agilent Technologies Inc. Add +6.1% 2.33% +0.10
THC Tenet Healthcare Corp. Add +7.1% 3.64% −0.09
ABT Abbott Laboratories Add +6.7% 2.45% −0.19

Options Activity Q3 2025 → Q4 2025
PUT - SPY 100 @ 684 EXP 01/30/2026 put New 300 $20.5M
PUT - SPY 100 @ 645 EXP 10/31/2025 put Sold out 300 $20.0Mbefore exit
PUT - SPY 100 @ 680 EXP 02/20/2026 put New 250 $17.0M
PUT - SPY 100 @ 688 EXP 01/30/2026 put New 250 $17.0M
PUT - SPY 100 @ 679 EXP 01/30/2026 put New 250 $17.0M
PUT - SPY 100 @ 682 EXP 01/30/2026 put New 250 $17.0M
PUT - SPY 100 @ 681 EXP 01/30/2026 put New 250 $17.0M
PUT - SPY 100 @ 683 EXP 01/30/2026 put New 250 $17.0M
PUT - SPY 100 @ 682 EXP 02/20/2026 put New 250 $17.0M
PUT - SPY 100 @ 635 EXP 10/31/2025 put Sold out 250 $16.7Mbefore exit
PUT - SPY 100 @ 660 EXP 10/31/2025 put Sold out 250 $16.7Mbefore exit
PUT - SPY 100 @ 655 EXP 10/31/2025 put Sold out 250 $16.7Mbefore exit
PUT - SPY 100 @ 660 EXP 11/21/2025 put Sold out 250 $16.7Mbefore exit
PUT - SPY 100 @ 658 EXP 10/31/2025 put Sold out 250 $16.7Mbefore exit
PUT - SPY 100 @ 659 EXP 10/31/2025 put Sold out 250 $16.7Mbefore exit
PUT - SPY 100 @ 639 EXP 10/31/2025 put Sold out 250 $16.7Mbefore exit
PUT - SPY 100 @ 659 EXP 11/21/2025 put Sold out 250 $16.7Mbefore exit

Calls and puts are listed by the shares they cover; their value is not part of the stock holdings above.

All Filings

QuarterPositions13F Reported ValueTop Holdings
Q2 2026 34$131.7MXBI, CAH, CALL- BSX 100 @ 75 EXP 04/17/2026, JNJ, MRK
Q1 2026 34$131.7MXBI, CAH, CALL- BSX 100 @ 75 EXP 04/17/2026, JNJ, MRK
Q4 2025 41$204.8MXBI, LLY, THC, MCK, HCA
Q3 2025 35$190.5MXBI, LLY, HCA, THC, DHR
Q2 2025 38$223.6MXBI, THC, HCA, MCK, UHS
Q1 2025 29$182.9MXBI, BSX, THC, HCA, LLY
Q4 2024 36$180.8MXBI, LLY, BSX, MCK, SYK
Q3 2024 33$234.6MXBI, LLY, THC, NVO, UHS
Q2 2024 37$223.9MLLY, NVO, MCK, THC, BSX
Q1 2024 46$275.1MXBI, LLY, NVO, BSX, TMO